DK2881108T3 - Forbedrede medicinske aerosolformuleringer - Google Patents

Forbedrede medicinske aerosolformuleringer Download PDF

Info

Publication number: DK2881108T3
Authority: DK; Denmark
Prior art keywords: aerosol formulations; improved medical; medical aerosol; improved; formulations
Prior art date: 2009-10-16

Application number

DK14199881.5T

Other languages

English (en)

Inventor

Rudi Mueller-Walz

Lise-Marie Fueg

Original Assignee

Jagotec Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-10-16

Filing date

2010-10-15

Publication date

2024-03-11

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41462450&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2881108(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2010-10-15 Application filed by Jagotec Ag filed Critical Jagotec Ag

2024-03-11 Application granted granted Critical

2024-03-11 Publication of DK2881108T3 publication Critical patent/DK2881108T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
- A61K9/124—Aerosols; Foams characterised by the propellant
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pulmonology (AREA)
Pain & Pain Management (AREA)
Otolaryngology (AREA)
Dispersion Chemistry (AREA)
Oil, Petroleum & Natural Gas (AREA)
Immunology (AREA)
Emergency Medicine (AREA)
Neurosurgery (AREA)
Rheumatology (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

DK14199881.5T 2009-10-16 2010-10-15 Forbedrede medicinske aerosolformuleringer DK2881108T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0918149.6A GB0918149D0 (en)	2009-10-16	2009-10-16	Improved medicinal aerosol formulation
EP10768922.6A EP2488158B1 (en)	2009-10-16	2010-10-15	Improved medicinal aerosol formulations

Publications (1)

Publication Number	Publication Date
DK2881108T3 true DK2881108T3 (da)	2024-03-11

Family

ID=41462450

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
DK10768922T DK2488158T3 (da)	2009-10-16	2010-10-15	Forbedrede medicinske aerosolformuleringer
DK14199881.5T DK2881108T3 (da)	2009-10-16	2010-10-15	Forbedrede medicinske aerosolformuleringer

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
DK10768922T DK2488158T3 (da)	2009-10-16	2010-10-15	Forbedrede medicinske aerosolformuleringer

Country Status (27)

Country	Link
US (3)	US20120282189A1 (da)
EP (3)	EP2881108B1 (da)
JP (5)	JP2013507430A (da)
CN (1)	CN102665675B (da)
AU (1)	AU2010305698C9 (da)
BR (1)	BR112012008983A2 (da)
CA (1)	CA2776359C (da)
CL (1)	CL2012000947A1 (da)
CY (1)	CY1116109T1 (da)
DK (2)	DK2488158T3 (da)
ES (2)	ES2973882T3 (da)
FI (1)	FI2881108T3 (da)
GB (1)	GB0918149D0 (da)
HK (2)	HK1173077A1 (da)
HR (2)	HRP20240402T1 (da)
HU (1)	HUE065583T2 (da)
IL (1)	IL219161B (da)
LT (1)	LT2881108T (da)
MX (1)	MX2012004337A (da)
NZ (1)	NZ599901A (da)
PL (2)	PL2881108T3 (da)
PT (2)	PT2881108T (da)
RS (2)	RS65391B1 (da)
SI (2)	SI2881108T1 (da)
SM (2)	SMT202400119T1 (da)
WO (1)	WO2011045432A1 (da)
ZA (1)	ZA201202452B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PL207377B1 (pl) *	2001-03-30	2010-12-31	Jagotec Ag	Medyczny preparat aerozolowy, sposób wytwarzania medycznego preparatu aerozolowego oraz zastosowanie soli kwasów karboksylowych jako środków pomocniczych w tym preparacie
GB0323684D0 (en)	2003-10-09	2003-11-12	Jagotec Ag	Improvements in or relating to organic compounds
GB0918149D0 (en)	2009-10-16	2009-12-02	Jagotec Ag	Improved medicinal aerosol formulation
TWI495466B (zh) *	2010-09-23	2015-08-11	Intech Biopharm Ltd	用於氣喘之吸入性複方組合物
GB201515310D0 (en) *	2015-08-27	2015-10-14	Jagotec Ag	Pharmaceutical composition

Family Cites Families (55)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2503962A1 (de)	1975-01-31	1976-08-05	Thomae Gmbh Dr K	Spruehbare mittel in suspensionsform zur anwendung auf der haut
FR2420972A1 (fr)	1978-03-31	1979-10-26	Roussel Uclaf	Application du peroxyde de thenoyle a titre de medicament
JPS5529524A (en)	1978-08-21	1980-03-01	Toyo Aerosol Kogyo Kk	Powdery aerosol composition
DE2914181C2 (de)	1979-04-07	1982-06-16	Kernforschungsanlage Jülich GmbH, 5170 Jülich	Verfahren und Vorrichtung zum Trocknen temperaturempfindlicher Güter der Pharma- und Nahrungsmittelindustrie
JPS6135815A (ja)	1984-07-28	1986-02-20	Sanshin Seisakusho:Kk	上部集液式加圧ろ過機に於ける機体内液の脱液方法及び同装置
FR2666962B1 (fr)	1990-09-26	1996-06-14	Oreal	Composition antifongique sous forme de spray sec.
SE9302777D0 (sv)	1993-08-27	1993-08-27	Astra Ab	Process for conditioning substances
SE9101090D0 (sv)	1991-04-11	1991-04-11	Astra Ab	Process for conditioning of water-soluble substances
US5874063A (en)	1991-04-11	1999-02-23	Astra Aktiebolag	Pharmaceutical formulation
NZ246421A (en) *	1991-12-18	1996-05-28	Minnesota Mining & Mfg	Aerosol formulation containing a drug and a propellant and which is substantially free of surfactant
DE4321288A1 (de)	1993-06-26	1995-01-05	Solvay Fluor & Derivate	Zusammensetzungen mit chlorfreien, gegebenenfalls wasserstoffhaltigen Fluorkohlenwasserstoffen
US6596260B1 (en)	1993-08-27	2003-07-22	Novartis Corporation	Aerosol container and a method for storage and administration of a predetermined amount of a pharmaceutically active aerosol
ATE233544T1 (de)	1993-12-02	2003-03-15	Abbott Lab	Aerosole als darreichungsform mit cfc-freiem treibmittel
ES2206572T3 (es)	1995-04-14	2004-05-16	Smithkline Beecham Corporation	Inhalador de dosis medida para salmeterol.
JP3707107B2 (ja)	1995-09-18	2005-10-19	鈴木油脂工業株式会社	薬剤分散液及びその製造方法
US6054488A (en)	1996-06-11	2000-04-25	3M Innovative Properties Company	Medicinal aerosol formulations of formoterol
US6361938B1 (en)	1996-11-08	2002-03-26	Elan Corporation, Plc	Peptides which enhance transport across tissues and methods of identifying and using the same
CA2279648C (en)	1997-01-30	2007-04-24	Alpenstock Holdings Limited	Haemostatic aerosol composition
ATE219355T1 (de)	1997-02-05	2002-07-15	Jago Res Ag	Medizinische aerosolformulierungen
US6086376A (en)	1998-01-30	2000-07-11	Rtp Pharma Inc.	Dry aerosol suspension of phospholipid-stabilized drug microparticles in a hydrofluoroalkane propellant
US6451285B2 (en)	1998-06-19	2002-09-17	Baker Norton Pharmaceuticals, Inc.	Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant
ATE283033T1 (de) *	1998-07-24	2004-12-15	Jago Res Ag	Medizinische aerosolformulierungen
PT1102579E (pt) *	1998-08-04	2003-07-31	Jago Res Ag	Formulacoes de aerossol medicinais
US7521068B2 (en)	1998-11-12	2009-04-21	Elan Pharma International Ltd.	Dry powder aerosols of nanoparticulate drugs
ES2192866T3 (es)	1998-11-13	2003-10-16	Jago Res Ag	Polvo seco para inhalacion.
US7074388B2 (en) *	1998-12-10	2006-07-11	Kos Life Science, Inc.	Water stabilized medicinal aerosol formulation
US6926911B1 (en)	1998-12-22	2005-08-09	The University Of North Carolina At Chapel Hill	Compounds and methods for the treatment of airway diseases and for the delivery of airway drugs
AU2879100A (en)	1999-02-12	2000-08-29	Miles A. Libbey Iii	Formulation and system for intra-oral delivery of pharmaceutical agents
GB9903759D0 (en)	1999-02-18	1999-04-14	Novartis Ag	Organic compounds
GB9904919D0 (en)	1999-03-03	1999-04-28	Novartis Ag	Organic compounds
GB0012260D0 (en)	2000-05-19	2000-07-12	Astrazeneca Ab	Novel composition
GB0012261D0 (en)	2000-05-19	2000-07-12	Astrazeneca Ab	Novel process
US20060257324A1 (en)	2000-05-22	2006-11-16	Chiesi Farmaceutici S.P.A.	Pharmaceutical solution formulations for pressurised metered dose inhalers
UA73986C2 (uk)	2000-05-22	2005-10-17	К'Єзі Фармачеутічі С.П.А.	АЕРОЗОЛЬНА КОМПОЗИЦІЯ, ЩО МІСТИТЬ <font face="Symbol">b</font>2-АДРЕНЕРГІЧНИЙ АГОНІСТ ТРИВАЛОЇ ДІЇ, ДОЗУЮЧИЙ ІНГАЛЯТОР ПІД ТИСКОМ ТА СПОСІБ ЙОГО ЗАПОВНЕННЯ
WO2002007672A2 (en) *	2000-07-19	2002-01-31	Aeropharm Technology, Inc.	A medicinal aerosol formulation
CA2417973A1 (en)	2000-08-04	2002-02-14	Longwood Pharmaceutical Research, Inc.	Formulations of mometasone and a bronchodilator for pulmonary administration
JP5021149B2 (ja)	2000-10-09	2012-09-05	スリーエムイノベイティブプロパティズカンパニー	医療用エアロゾル調合物
PL207377B1 (pl)	2001-03-30	2010-12-31	Jagotec Ag	Medyczny preparat aerozolowy, sposób wytwarzania medycznego preparatu aerozolowego oraz zastosowanie soli kwasów karboksylowych jako środków pomocniczych w tym preparacie
US6455028B1 (en)	2001-04-23	2002-09-24	Pharmascience	Ipratropium formulation for pulmonary inhalation
GB0208742D0 (en)	2002-04-17	2002-05-29	Bradford Particle Design Ltd	Particulate materials
AR036358A1 (es)	2001-08-28	2004-09-01	Schering Corp	Un inhalador de dosis medidas que contiene una formulacion de suspension en aerosol para inhalacion, un proceso para la produccion de la formulacion, el producto y el uso de una formulacion para la manufactura de un medicamento de asma
GB0201400D0 (en)	2002-01-22	2002-03-13	Glaxo Group Ltd	Novel apparatus and process
SI3494995T1 (sl)	2002-03-01	2020-08-31	Chiesi Farmaceutici S.P.A.	Superfina formulacija formoterola
GB0207899D0 (en)	2002-04-05	2002-05-15	3M Innovative Properties Co	Formoterol and cielesonide aerosol formulations
US7582284B2 (en)	2002-04-17	2009-09-01	Nektar Therapeutics	Particulate materials
EP1531866A1 (en) *	2002-08-29	2005-05-25	Cipla Ltd.	Pharmaceutical products and compositions comprising specific anticholinergic agents, beta-2 agonists and corticosteroids
US20060193610A1 (en)	2003-07-12	2006-08-31	Jong-Hun Han	Aromatic emitting apparatus for using cigarjack
EP1670442A4 (en)	2003-09-19	2011-09-14	Penwest Pharmaceuticals Co	DOSAGE FORMS WITH DELAYED RELEASE
GB0323685D0 (en) *	2003-10-09	2003-11-12	Jagotec Ag	Improvements in or relating to organic compounds
GB0323684D0 (en)	2003-10-09	2003-11-12	Jagotec Ag	Improvements in or relating to organic compounds
DE602005009012D1 (de) *	2004-10-12	2008-09-25	Generics Uk Ltd	Rmulierungen, worin die partikel durch präzipition in einem aerosolbehälter gebildet werden
GB0918149D0 (en) *	2009-10-16	2009-12-02	Jagotec Ag	Improved medicinal aerosol formulation
GB0918150D0 (en)	2009-10-16	2009-12-02	Jagotec Ag	Improved formulations
JP2015036045A (ja) *	2013-08-12	2015-02-23	株式会社泉技研	骨質改善のための超音波音響システム及び超音波音響機器の作動方法
JP6135815B1 (ja)	2016-09-29	2017-05-31	東洋インキＳｃホールディングス株式会社	プリント配線板および電子機器

2009
- 2009-10-16 GB GBGB0918149.6A patent/GB0918149D0/en not_active Ceased
2010
- 2010-10-15 SI SI201032141T patent/SI2881108T1/sl unknown
- 2010-10-15 AU AU2010305698A patent/AU2010305698C9/en active Active
- 2010-10-15 FI FIEP14199881.5T patent/FI2881108T3/fi active
- 2010-10-15 PT PT141998815T patent/PT2881108T/pt unknown
- 2010-10-15 DK DK10768922T patent/DK2488158T3/da active
- 2010-10-15 CA CA2776359A patent/CA2776359C/en active Active
- 2010-10-15 NZ NZ599901A patent/NZ599901A/xx unknown
- 2010-10-15 PL PL14199881.5T patent/PL2881108T3/pl unknown
- 2010-10-15 HR HRP20240402TT patent/HRP20240402T1/hr unknown
- 2010-10-15 ES ES14199881T patent/ES2973882T3/es active Active
- 2010-10-15 US US13/503,245 patent/US20120282189A1/en not_active Abandoned
- 2010-10-15 PL PL10768922T patent/PL2488158T3/pl unknown
- 2010-10-15 EP EP14199881.5A patent/EP2881108B1/en active Active
- 2010-10-15 JP JP2012533650A patent/JP2013507430A/ja active Pending
- 2010-10-15 HU HUE14199881A patent/HUE065583T2/hu unknown
- 2010-10-15 LT LTEP14199881.5T patent/LT2881108T/lt unknown
- 2010-10-15 BR BR112012008983A patent/BR112012008983A2/pt not_active Application Discontinuation
- 2010-10-15 PT PT10768922T patent/PT2488158E/pt unknown
- 2010-10-15 CN CN201080046310.7A patent/CN102665675B/zh active Active
- 2010-10-15 RS RS20240366A patent/RS65391B1/sr unknown
- 2010-10-15 EP EP23219752.5A patent/EP4327807A3/en active Pending
- 2010-10-15 RS RS20150160A patent/RS53883B1/en unknown
- 2010-10-15 SM SM20240119T patent/SMT202400119T1/it unknown
- 2010-10-15 ES ES10768922.6T patent/ES2533372T3/es active Active
- 2010-10-15 EP EP10768922.6A patent/EP2488158B1/en not_active Revoked
- 2010-10-15 SI SI201030889T patent/SI2488158T1/sl unknown
- 2010-10-15 WO PCT/EP2010/065573 patent/WO2011045432A1/en active Application Filing
- 2010-10-15 DK DK14199881.5T patent/DK2881108T3/da active
- 2010-10-15 MX MX2012004337A patent/MX2012004337A/es active IP Right Grant
2012
- 2012-04-04 ZA ZA2012/02452A patent/ZA201202452B/en unknown
- 2012-04-13 CL CL2012000947A patent/CL2012000947A1/es unknown
- 2012-04-15 IL IL219161A patent/IL219161B/en active IP Right Grant
2013
- 2013-01-09 HK HK13100348.4A patent/HK1173077A1/xx not_active IP Right Cessation
2014
- 2014-05-16 US US14/279,751 patent/US20140314684A1/en not_active Abandoned
2015
- 2015-02-16 HR HRP20150174TT patent/HRP20150174T1/hr unknown
- 2015-02-26 JP JP2015036045A patent/JP2015129162A/ja active Pending
- 2015-03-06 SM SM201500052T patent/SMT201500052B/xx unknown
- 2015-03-13 CY CY20151100253T patent/CY1116109T1/el unknown
- 2015-12-03 HK HK15111930.3A patent/HK1211207A1/xx unknown
2016
- 2016-09-14 US US15/265,467 patent/US10471077B2/en active Active
- 2016-12-27 JP JP2016252909A patent/JP6568511B2/ja active Active
2019
- 2019-08-02 JP JP2019142684A patent/JP7203701B2/ja active Active
2022
- 2022-12-27 JP JP2022209895A patent/JP2023026517A/ja active Pending

Also Published As

Publication number	Publication date
RS65391B1 (sr)	2024-04-30
EP2488158B1 (en)	2014-12-24
CY1116109T1 (el)	2017-02-08
EP2488158A1 (en)	2012-08-22
EP2881108B1 (en)	2023-12-27
JP7203701B2 (ja)	2023-01-13
HK1211207A1 (en)	2016-05-20
AU2010305698C9 (en)	2014-04-17
IL219161B (en)	2019-12-31
WO2011045432A1 (en)	2011-04-21
JP6568511B2 (ja)	2019-08-28
JP2019182878A (ja)	2019-10-24
AU2010305698C1 (en)	2013-07-25
ES2533372T3 (es)	2015-04-09
US10471077B2 (en)	2019-11-12
CA2776359C (en)	2015-12-08
US20140314684A1 (en)	2014-10-23
IL219161A0 (en)	2012-06-28
JP2013507430A (ja)	2013-03-04
JP2015129162A (ja)	2015-07-16
PT2881108T (pt)	2024-03-13
JP2017057223A (ja)	2017-03-23
CL2012000947A1 (es)	2012-12-14
PL2488158T3 (pl)	2015-06-30
BR112012008983A2 (pt)	2016-04-05
GB0918149D0 (en)	2009-12-02
SMT202400119T1 (it)	2024-05-14
HK1173077A1 (en)	2013-05-10
CA2776359A1 (en)	2011-04-21
PT2488158E (pt)	2015-03-16
PL2881108T3 (pl)	2024-06-17
LT2881108T (lt)	2024-04-10
ZA201202452B (en)	2013-09-25
HRP20150174T1 (hr)	2015-05-22
EP2881108A1 (en)	2015-06-10
MX2012004337A (es)	2012-08-31
CN102665675A (zh)	2012-09-12
EP4327807A2 (en)	2024-02-28
FI2881108T3 (fi)	2024-03-13
SI2881108T1 (sl)	2024-04-30
EP4327807A3 (en)	2024-04-24
JP2023026517A (ja)	2023-02-24
HUE065583T2 (hu)	2024-06-28
DK2488158T3 (da)	2015-03-23
US20170189423A1 (en)	2017-07-06
US20120282189A1 (en)	2012-11-08
SMT201500052B (it)	2015-05-05
AU2010305698A1 (en)	2012-04-26
NZ599901A (en)	2013-08-30
CN102665675B (zh)	2014-03-19
ES2973882T3 (es)	2024-06-24
HRP20240402T1 (hr)	2024-06-07
RS53883B1 (en)	2015-08-31
SI2488158T1 (sl)	2015-04-30
AU2010305698B2 (en)	2012-12-20

Publication	Publication Date	Title
DK3061445T3 (da)	2023-09-11	Højkoncentrerede farmaceutiske formuleringer
BR112012030950A2 (pt)	2016-11-01	formulações de vacina
EP2513299A4 (en)	2013-12-11	ADIPEOUS FABRIC DECELLULARIZED
SMT201400069B (it)	2014-07-07	Formulazione farmaceutica
EP2430991A4 (en)	2012-04-18	MEDICAL MANIPULATOR
GT201200303A (es)	2014-04-29	Formulaciones farmacéuticas
BRPI1009465A2 (pt)	2015-08-18	Formulação
DE112010000740A5 (de)	2012-09-13	Endoskop
BRPI0922653A2 (pt)	2016-01-05	preparação farmacêutica
SMT202100150T1 (it)	2021-05-07	Formulazioni migliorate
DE112011103919A5 (de)	2013-10-24	Endoskop
EP2384199A4 (en)	2013-09-25	IMPROVED MEDICAL IMPLANT
HK1211207A1 (en)	2016-05-20	Improved medicinal aerosol formulations
BRPI1013462A2 (pt)	2015-09-01	Formulações herbicidas
DK2467136T3 (da)	2014-08-11	4-methylpyrazolformuleringer
FR2967069B3 (fr)	2012-11-16	Formulations
DK2598472T3 (da)	2015-07-06	Formuleringer
BRPI1008983A2 (pt)	2016-03-22	formulação farmacêutica
ITPG20080044A1 (it)	2010-02-28	Barriera aerosol dentale -rm5
FI20080012A0 (fi)	2008-01-08	Farmaseuttiset formulaatiot
FI20080013A0 (fi)	2008-01-08	Uudet farmaseuttiset formulaatiot
CN301099620S (zh)	2009-12-30	消毒柜(MXV-ZLP80m6)
CN301099621S (zh)	2009-12-30	消毒柜(mxv-zlp90q05)
CN301140906S (zh)	2010-02-17	消毒柜(mxv-zlp90q06)
CN301238785S (zh)	2010-05-26	消毒柜(mvx-zlp110q05)